(Q39798025)

14 September 2017

title

Transglutaminase 2 as a cisplatin resistance marker in non-small cell lung cancer (English)

1 reference

14 September 2017

1 reference

1 reference

Kang-Seo Park

1

1 reference

14 September 2017

Hyun-Kyoung Kim

2

1 reference

14 September 2017

Jung-Hwa Lee

3

1 reference

14 September 2017

Yong-Bock Choi

4

1 reference

14 September 2017

Seong-Yeol Park

5

1 reference

14 September 2017

Sei-Hoon Yang

6

1 reference

14 September 2017

Soo-Youl Kim

7

1 reference

14 September 2017

Kyeong-Man Hong

8

1 reference

14 September 2017

publication date

18 September 2009

1 reference

Journal of Cancer Research and Clinical Oncology

14 September 2017

published in

1 reference

14 September 2017

volume

136

1 reference

14 September 2017

issue

4

1 reference

14 September 2017

page(s)

493-502

1 reference

https://scigraph.springernature.com/pub.10.1007/s00432-009-0681-6

14 September 2017

exact match

0 references

cites work

Mechanisms of resistance to cisplatin

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00432-009-0681-6

Epidermal growth factor receptor gene and protein and gefitinib sensitivity in non-small-cell lung cancer

21 January 2018

1 reference

12 December 2020

Aurora-A regulation of nuclear factor-kappaB signaling by phosphorylation of IkappaBalpha

1 reference

12 December 2020

Nuclear factor-kappaB inhibitors as sensitizers to anticancer drugs

1 reference

12 December 2020

High levels of transglutaminase expression in doxorubicin-resistant human breast carcinoma cells

1 reference

12 December 2020

Adenovirus-mediated inhibitor kappaB gene transfer improves the chemosensitivity to anticancer drugs in human lung cancer in vitro and in vivo.

1 reference

12 December 2020

Tissue transglutaminase protects epithelial ovarian cancer cells from cisplatin-induced apoptosis by promoting cell survival signaling

1 reference

12 December 2020

Applications of genomics in NSCLC.

1 reference

12 December 2020

14-3-3sigma methylation in pretreatment serum circulating DNA of cisplatin-plus-gemcitabine-treated advanced non-small-cell lung cancer patients predicts survival: The Spanish Lung Cancer Group

1 reference

12 December 2020

Expression of multidrug resistance protein-related genes in lung cancer: correlation with drug response.

1 reference

12 December 2020

Transfer of IkappaBalpha gene increase the sensitivity of paclitaxel mediated with caspase 3 activation in human lung cancer cell

1 reference

12 December 2020

Tissue transglutaminase regulates focal adhesion kinase/AKT activation by modulating PTEN expression in pancreatic cancer cells

1 reference

12 December 2020

Regulation of the expression of the tissue transglutaminase gene by DNA methylation

1 reference

12 December 2020

Identification of chemical inhibitors to human tissue transglutaminase by screening existing drug libraries

1 reference

12 December 2020

Effect of BRCA1 haplotype on survival of non-small-cell lung cancer patients treated with platinum-based chemotherapy

1 reference

12 December 2020

The NF-kappa B and I kappa B proteins: new discoveries and insights

1 reference

12 December 2020

The transglutaminase 2 gene (TGM2), a potential molecular marker for chemotherapeutic drug sensitivity, is epigenetically silenced in breast cancer

1 reference

12 December 2020

Mitomycin, ifosfamide, and cisplatin in unresectable non-small-cell lung cancer: effects on survival and quality of life

1 reference

12 December 2020

Transglutaminase 2 in inflammation

1 reference

12 December 2020

Reversal of drug resistance in breast cancer cells by transglutaminase 2 inhibition and nuclear factor-kappaB inactivation

1 reference

12 December 2020

Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer

1 reference

12 December 2020

Regulation of platelet-derived growth factor receptor function by integrin-associated cell surface transglutaminase

1 reference

12 December 2020

Cisplatin and DNA repair in cancer chemotherapy

1 reference

12 December 2020

Prognostic significance of tissue transglutaminase in drug resistant and metastatic breast cancer

1 reference

12 December 2020

Customizing Cisplatin Based on Quantitative Excision Repair Cross-Complementing 1 mRNA Expression: A Phase III Trial in Non–Small-Cell Lung Cancer

1 reference

12 December 2020

Association between polymorphisms of ERCC1 and XPD and survival in non-small-cell lung cancer patients treated with cisplatin combination chemotherapy

1 reference

12 December 2020

Paclitaxel sensitivity of breast cancer cells with constitutively active NF-kappaB is enhanced by IkappaBalpha super-repressor and parthenolide

1 reference

12 December 2020

A new regulatory mechanism of NF-kappaB activation by I-kappaBbeta in cancer cells

1 reference

12 December 2020

MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling

1 reference

12 December 2020

Increase in transglutaminase 2 expression is associated with NF-kappaB activation in breast cancer tissues.

1 reference

12 December 2020

Formation and repair of cisplatin-induced adducts to DNA in cultured normal and repair-deficient human fibroblasts.

1 reference

12 December 2020

Glucosamine is an effective chemo-sensitizer via transglutaminase 2 inhibition

1 reference

12 December 2020

Chemotherapy versus supportive care in advanced non-small cell lung cancer: improved survival without detriment to quality of life

1 reference

12 December 2020

Transglutaminase 2 protects against ischemic insult, interacts with HIF1beta, and attenuates HIF1 signaling

1 reference

12 December 2020

Transglutaminase 2 mediates polymer formation of I-kappaBalpha through C-terminal glutamine cluster

1 reference

12 December 2020

Activation in vitro of NF-kappa B by phosphorylation of its inhibitor I kappa B

1 reference

12 December 2020

Inactivation of LLC1 gene in nonsmall cell lung cancer

1 reference

12 December 2020

Semiautomatic detection of DNA methylation at CpG islands

1 reference

12 December 2020

10.1007/S00432-009-0681-6

Identifiers

DOI

1 reference

14 September 2017

1 reference